Marissa Zwan

Affiliations: 
VU University Medical Center, Amsterdam, Netherlands 
Google:
"Marissa Zwan"
Mean distance: 106866 (cluster 48)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Collij LE, Farrar G, Zwan M, et al. (2023) Clinical outcomes up to 9 years after [F]flutemetamol amyloid-PET in a symptomatic memory clinic population. Alzheimer's Research & Therapy. 15: 207
Ingala S, van Maurik IS, Altomare D, et al. (2022) Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease. European Radiology
van der Doelen DM, Handels RLH, Zwan MD, et al. (2022) The Impact of Amyloid PET Disclosure on Quality of Life in Patients With Young Onset Dementia. Alzheimer Disease and Associated Disorders. 36: 1-6
Collij LE, Salvadó G, Shekari M, et al. (2021) Visual assessment of [F]flutemetamol PET images can detect early amyloid pathology and grade its extent. European Journal of Nuclear Medicine and Molecular Imaging
Reimand J, de Wilde A, Teunissen CE, et al. (2019) PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases. Alzheimer's Research & Therapy. 11: 100
de Wilde A, Ossenkoppele R, Pelkmans W, et al. (2019) Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
de Wilde A, Reimand J, Teunissen CE, et al. (2019) Discordant amyloid-β PET and CSF biomarkers and its clinical consequences. Alzheimer's Research & Therapy. 11: 78
Rodríguez-Gómez O, Rodrigo A, Iradier F, et al. (2019) The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Handels R, Zwan MD, Pelkmans W, et al. (2019) Added Diagnostic Value Of 18F-Flutemetamol Pet Scanning In Young Patients With Dementia Alzheimers & Dementia. 15
Willemse EAJ, van Maurik IS, Tijms BM, et al. (2018) Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer's disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE project. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 563-572
See more...